SCHEDULE: Rosalind Entities Disclose 9.9% Stake in PolyPid Ltd.
Schedule 13G Amendment No. 5
Rosalind Advisors and affiliated entities report a 9.9% beneficial ownership stake in PolyPid Ltd., including warrants subject to a 9.99% blocker provision.
Summary
- Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon collectively reported beneficial ownership of 5,705,555 shares of PolyPid Ltd. Common Stock.
- This represents 9.9% of PolyPid Ltd.'s outstanding common stock, calculated based on 15,897,201 ordinary shares as of July 27, 2025.
- The reported ownership includes 918,668 shares of Common Stock and 4,786,887 shares issuable upon the exercise of warrants.
- A blocker provision prevents the exercise of warrants if it would result in beneficial ownership exceeding 9.99% of the Common Stock.
- Due to these blockers, the Reporting Persons were not able to exercise any of the warrants as of the filing event date, limiting their current shared voting and dispositive power to 918,668 shares.
Sentiment
Score: 5
Explanation: This is a factual disclosure of beneficial ownership, not an operational or financial performance report, thus maintaining a neutral sentiment.
Positives
- Rosalind Advisors, Inc. and affiliated entities hold a significant 9.9% beneficial ownership stake in PolyPid Ltd., indicating a notable institutional interest in the company.
Negatives
- The reporting persons are currently unable to exercise 4,786,887 shares issuable upon warrants due to a 9.99% blocker provision, limiting their immediate voting and dispositive power over these potential shares.
Future Outlook
The filing does not contain any forward-looking statements or guidance from PolyPid Ltd. or the reporting persons regarding the issuer's future performance or strategy.
Industry Context
This filing is a standard disclosure of beneficial ownership by an institutional investor group, which is a common occurrence in the public markets. It does not provide specific insights into broader industry trends or competitive landscape for PolyPid Ltd.
Stakeholder Impact
- Shareholders may note the continued significant institutional ownership by Rosalind entities, which could be perceived as a vote of confidence in PolyPid Ltd.
Key Dates
| Date | Description |
|---|---|
| 2025-07-27 | Date as of which 15,897,201 Ordinary shares of PolyPid Ltd.'s common stock were outstanding. |
| 2025-07-29 | Date of PolyPid Ltd.'s F-3 Filing, which provided the outstanding share count. |
| 2025-09-30 | Date of event which requires filing of this statement (Amendment No. 5). |
| 2025-11-12 | Signature date for Rosalind Advisors, Inc., Steven Salamon, Gil Aharon, and Rosalind Master Fund L.P. |
Keywords
PolyPid Ltd., Rosalind Advisors, Schedule 13G, beneficial ownership, warrants, M8001Q126, institutional investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.